Diamond-Blackfan Anemia 6

Search Trials
Safety Study of Gene Modified Donor T-cells Following TCR Alpha Beta Depleted Stem Cell Transplant
Status:
Active, not recruiting
Last Changed:
Jul 12, 2022
First Changed:
Feb 19, 2014
Disease(s):
Acute Lymphoblastic Leukemia
Intervention(s):
BPX-501 T cellsrimiducid
CD34+ (Malignant) Stem Cell Selection for Patients Receiving Allogenic Stem Cell Transplant
Status:
Recruiting
Last Changed:
Jun 18, 2020
First Changed:
Feb 13, 2014
Disease(s):
Chronic Myeloid Leukemia (CML)
Intervention(s):
CliniMACS CD34+ Reagent SystemThiotepaCyclophosphamideAlemtuzumabTacrolimusMelphalanBusulfanFludarabineMethylprednisolone
Reduced Intensity Conditioning for Non-Malignant Disorders Undergoing UCBT, BMT or PBSCT
Status:
Recruiting
Last Changed:
May 10, 2022
First Changed:
Oct 14, 2013
Disease(s):
Primary Immunodeficiency (PID)
Intervention(s):
HydroxyureaAlemtuzumabFludarabineMelphalanThiotepa
Investigation of the Genetics of Hematologic Diseases
Status:
Recruiting
Last Changed:
Jun 7, 2022
First Changed:
Mar 28, 2016
Disease(s):
Bone Marrow Failure Syndromes
Safety Study of Gene Modified Donor T Cell Infusion After Stem Cell Transplant for Non-Malignant Diseases
Status:
Active, not recruiting
Last Changed:
Jul 12, 2022
First Changed:
Sep 4, 2014
Disease(s):
Primary Immune Deficiency Disorders
Intervention(s):
BPX-501 and AP1903

Connect. Empower. Inspire.